R. Jonathan Henderson, MD

Dr. R. Jonathan Henderson obtained a Bachelor of Science Degree at LSU in Baton Rouge in microbiology. After receiving his M.D. at LSU Medical Center in Shreveport, he completed his internship and residency in Urology at LSUMC Hospital.

Schedule Appointment

Meet The Doctor

Dr. Henderson spent the next six years in practice in Alabama. During this time, he served as a representative of Alabama to the Southeastern Section of the American Urology Association. He also served as an assistant clinical professor of Urology at the University of Alabama.

Dr. Henderson is married to Dr. Leigh Henderson. They have two boys and two girls. His interests outside the office include hunting, fishing, gardening and snow skiing.

Education/Certifications

Dr. Henderson is certified by the American Board of Urology. He focuses his practice primarily on robotic surgeries and the treatment of prostate cancer. He is a member of the American Urologic Association, Shreveport Medical Society, Louisiana State Medical Society, the Society of Laparoscopic Surgeons, and the Alpha Omega Alpha Medical Honor Society. He has been on the LUGPA Board of Directors since 2011 and has been a past president.

Clinic Locations

Centerview Surgery Center

1310 Centerview Dr 
Little Rock, AR 72211
(501) 410-1127M - F: 6AM - 5PM

Little Rock

1300 Centerview Dr 
Little Rock, AR 72211
(501) 219-8900M - F: 7:30AM - 5 PM

Professional Memberships

Medical Association of the State of Alabama,

1996 - 2002

American Association of Clinical Urologists,

1997 - Present

American Urological Association,

1992 - Present

Medical Society of Etowah County, Alabama

1996 - 2002

American Medical Association,

1987 - 2009

Alpha Omega Alpha

1991 - Present

Shreveport Medical Society

2002 - Present

Louisiana State Urological Society

2002 - Present

Society of Laparoendoscopic Surgeons

1996 - 2013

Large Urology Group Practice Association, (LUGPA)

2008 - Present

American Society of Clinical Oncology (ASCO)

2015 - Present

Society of Urologic Oncology (SUO)

2016 - Present

Leadership Positions in Professional Organizations

Large Urology Group Practice Association (LUGPA)

Board of Directors

2011 - present

LUGPA President

2020 - present

LUGPA Secretary

2016 - 2018

LUGPA President-Elect

2018 - present

LUGPA Communications Committee Chairman

2013 - 2016

LUGPA Representative to the JAC (Joint Advocacy Conference),

2013 - 2017

LUGPA Finance Committee

2016 - present

LUGPA Annual Program Committee, Chairman

2016 - 2018

Member

2016 - present

LUGPA Regional Meeting Program Committee, Chairman

2016 - 2018

State of Louisiana

Governor’s Transition Committee on Ethics Reform

2008 – 2009

Louisiana Health Care Commission, LSMS Delegate,

2004 – 2009

American Association of Clinical Urologists (AACU)

AACU State Society Network Louisiana, Representative

2006 - 2020

AACU Board of Directors, Southeastern Section Representative

2013 - 2017

AACU Health Policy Chairman

2017 - 2020

UROPAC

Board of Directors, LUGPA Representative

2014 - 2016

UROPAC Vice Chairman

2017 - 2020

American Urological Association (AUA)

AUA Public Policy Council, (formerly Health Policy Council), Southeast Section Representative

2008 - 2014

AACU Representative

2017 - 2020

AUA National Insurance Advisory Workgroup (NIAW; previously known as CAC); Louisiana Representative

2005 - present

AUA Legislative Affairs Committee, Southeast Section Representative

2017 - present

Southeastern Section AUA

Health Policy Council, Vice-Chair

2012 - 2017

Chairman

2018 - 2020

Bylaws Committee

2013 - 2019

Board of Directors, Louisiana Representative

2004 - 2009, 2015 - 2018

Board of Directors, Alabama Representative

1999 - 2002

Louisiana Urological Society

Director of Development

2019 - present

Immediate Past President

2017 - 2018

President

2016 - 2017

President-Elect

2015

State Society Network Representative

2006 - present

Carrier Advisory Committee Representative

2005 - present

Louisiana State Medical Society

Louisiana Medical Society Public Health & Legislative Commission

2007

Louisiana State Medical Society House of Delegates, Delegate

2006, 2007, 2010

Louisiana Health Care Commission

2004 - 2009

Louisiana State Medical Society Physician and Patient Advocacy Committee

2007 - 2008

Shreveport Medical Society

Shreveport Medical Society Membership Committee

2007 - 2008

Shreveport Medical Society Public Health and Legislative Committee

2008 - 2012

Alabama Medical Society

1996 - 2002

Medical Society of Etowah County V. P.

1996 - 97, 2001 - 2002

Gadsden Regional Medical Center Department of Urology Chairman

1999 - 2001

Medical Society of Etowah County V. P.

1996- 97, 2001-2002

Janssen Pharmaceuticals, Zytiga Speaker’s Bureau

2013 - present

Erleada Speaker’s Bureau

2018 - present

Astellas advisor

2020 - present

AstraZeneca, consultant

2019 - present

Sanofi consultant

2018 - present

Myriad Genetics Speaker

2014 - present

Clovis Pharmaceuticals, Strategic Council

2019 - present

Published Writings Details

The Impact of Late LHRH Agonist Dosing on Testosterone Suppression in Prostate Cancer Patients: An Analysis of US Clinical Data.

Crawford, ED; Twardowski, PW; Concepcion, RS; Hafron, JM; Harris, RG; Moul, JW; Gordon, LN; Petrylak, DP; Atkinson, S; Boldt-Houle, D; Keane, TE; Higano, CS; et al.JUrol.2020, Apr; 203(4):743-750

Urologist’s Perspective: COVID-19 provides tough decisions and valuable lessons. Urology Times.

August, 2020

Urologists in Cancer Care, a division of Urology Times,Editor

2020

Grand Rounds in Urology, Section Editor, nmCRPC Learning Center

2019

The LUGPA Alternative Payment Model for Initial Therapy of Newly Diagnosed Patients with Organ-confined Prostate Cancer: Rationale and Development.

Kapoor, DA; Shore, ND; Kirsh, GM; Henderson, RJ; Cohen, TD; Latino, K. Rev Urol. 2017; 19(4):235-245

Use of a 17-Gene Prognostic Assay in Contemporary Urologic Practice: Results of an Interim Analysis in an Observational Cohort.

Eure G, Germany R, Given R, Ruixiao L, Shindel A, Rothney M, Glowacki R, Henderson J, et al. Urology 2017; 107 67-75.

Practice Management for Urology Groups; First Edition;

2016; Editor

Glypican-1 as a biomarker for Prostate Cancer

Shore, N; Concepcion, R; Saltzstein, D; Paivanas, T; BeebeDimmer, J; Ruterbusch, J; Justiniano, I; Mazure, H; Nocon, A; Soon, J; Truong, Q; Wissmuller, S; Campbell, D; Walsh, B. Presented May 17, 2015, AUA, Late Breaking Abstract.

The 4Kscore Test is a predictor of High Grade Prostate Cancer on Biopsy.

Lin, D; McGee,S; Riege-Christ, K; Shore,N; Peiczonka,C; Cochran,J; Concepcion,R; Dumbadze,I; Deck,K; Bailen,J; Henderson, RJ; Sieber,P; Langford,TD; Asroff, S;Waldmann,T. Presented May 18, 2014, AUA, Late Breaking Abstract

Combination therapy with finasteride and tadalafil once daily for 6 months: A randomized, placebo-controlled study in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.

Casabe, AR; Roehrborn, C; DaPozza, LF; Zepeda, S; Henderson, R; et al. J Urol 191:727. Presented at EAU 2013

PROGENSA PCA 3 molecular urine test as a predictor of repeat negative biopsies: A prospective multicenter clinical study.

Gittleman M, Hertzman B, Bailen J, Franco N, Williams T, Korziol I, Henderson RJ, Efros M, Bidair M, Ward JF. J Urol 2013 190:64

Centers of Excellence Concept and Penile Prostheses: An Outcome Analysis.

Henry G, Kansal N, Callaway M, Grigsby T, Henderson J, et al. J Urol 2009 181(3):1264-1268

Renal Cell Carcinoma in an Intrathoracic Kidney: Radiographic Findings and Surgical Considerations.

William S. Kubricht, R. Jonathan Henderson, et al Southern Medical Journal 92.No.6:628

Prostate Specific Antigen (PSA) and PSA Density are Higher in African-American Men without Prostate Cancer.

R. J. Henderson, (et al). Journal of The National Cancer Institute 89(2): 134-138. Presented at AUA Annual Meeting, Orlando, Florida, May 12, 1996.

Fat Density in Renal Cell Carcinoma: Demonstration with Tomography

R. J. Henderson, (et al) Journal of Urology 157:1347

Analysis of Immunological Alterations Associated with Testicular Prostheses.

J. Henderson (et al) Journal of Urology 154:1748 Presented at: Southeastern Section of AUA, March 1994; Society for Basic Urologic Research, May 1994; Southern Medical Association November, 1994.

Evaluation of Predictors of Progression in Pathologic Stage C Prostate Cancer.

T. Bourque, D. Culkin, J. Henderson, R. Zitman, J. Mata and D. Venable. Presented at: Southeastern Section of AUA. March 1994; Society for Basic Urology Research, May 1994.

Typing and Plasmid Analysis of Clinical Isolates of Group A Beta-Hemolytic Streptococcus with increased Resistance to Erythromycin.

J. Henderson, (et al) Presented at Southern Society for Pediatric Research/American Federation of Clinical Research, January 1990.

Isolation and Identification of a H+ATPase from Rabbit Reticulocyte Endosome.

L. Cai-Yuan, R. J. Henderson, A. Watkins, J. Glass. Presented at American Society of Hematology, December 1988.

Salmonella Transmission in the Turtle Farming Industry. USDA Grant.

J. Henderson, R. Siebeling, 1987.

Presence of Vibrio Species in Commercially Available Shellfish. Louisiana Department of Health and Human Resources Grant.

L. Ford, R.J. Henderson, 1987.

Find A Physician